Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake

Hepatology

Volumn 57, Issue 1, 2013, Pages 258-265

  Dam, Gitte ^a   Keiding, Susanne ^a   Munk, Ole L ^a   Ott, Peter ^a   Vilstrup, Hendrik ^a   Bak, Lasse K ^b   Waagepetersen, Helle S ^b   Schousboe, Arne ^b   Sørensen, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; OXYGEN;

ADULT; AGED; AMMONIA BLOOD LEVEL; ARTERIAL BLOOD; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN OXYGEN CONSUMPTION; BRAIN TISSUE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL;

ADULT; AGED; AMMONIA; BLOOD-BRAIN BARRIER; CEREBROVASCULAR CIRCULATION; CEREBRUM; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; MALE; MIDDLE AGED; OXYGEN; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;

EID: 84872157341     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25995     Document Type: Article

References (31)

1. Rama Rao KV, Norenberg MD. Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. Neurochem Int 2012; 60: 697-706.
2. Philips BJ, Armstrong IR, Pollock A, Lee A. Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation. HEPATOLOGY 1998; 27: 369-376.
3. Morgan MY, Jakobovits AW, James IM, Sherlock S. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology 1980; 78: 663-670.
4. Almdal T, Schroeder T, Ranek L. Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver diseases. Scand J Gastroenterol 1989; 24: 299-303.
5. Iversen P, Sørensen M, Bak LK, Waagepetersen HS, Vafaee MS, Borghammer P, et al. Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. Gastroenterology 2009; 136: 863-871.
6. Ikeda K, Tsuji H, Azuma K, Hashiguchi M, Ogata H, Ibayashi S, et al. Alteration of regional cerebral metabolism in patients with cirrhosis in positron emission tomography. Fukuoka Igaku Zasshi 2001; 92: 306-314.
7. Norenberg MD, Rama Rao KV, Jayakumar AR. Signaling factors in the mechanism of ammonia neurotoxicity. Metab Brain Dis 2009; 24: 103-117.
8. Zwingmann C, Chatauret N, Leibfritz D, Butterworth RF. Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. HEPATOLOGY 2003; 37: 420-428.
9. Gorg B, Morwinsky A, Keitel V, Qvartskhava N, Schrör K, Häussinger D. Ammonia triggers exocytotic release of L-glutamate from cultured rat astrocytes. Glia 2010; 58: 691-705.
10. Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, et al. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 1979; 63: 449-460.
11. 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. HEPATOLOGY 2006; 43: 42-50. Erratum, HEPATOLOGY 2006;44:1056.
12. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716-721.
13. Elsass P, Hartelius H. Reaction time and brain disease: relations to location, etiology and progression of cerebral dysfunction. Acta Neurol Scand 1985; 71: 11-19.
14. van Anken HC, Schiphorst ME. A kinetic determination of ammonia in plasma. Clin Chim Acta 1974; 56: 151-157.
15. Conn HO. Further observations on the lack of effect of isoniazid on the blood ammonia concentration. Am Rev Respir Dis 1965; 91: 108-111.
16. Munk OL, Keiding S, Bass L. A method to estimate dispersion in sampling catheters and to calculate dispersion-free blood time-activity curves. Med Phys 2008; 35: 3471-3481.
17. 13N-ammonia metabolites in blood. Metab Brain Dis 2010; 25: 49-56.
18. Talairach J. Co-planar stereotaxic atlas of the human brain. Volume 1988. New York: Thieme.
19. Eichling JO, Raichle ME, Grubb RL Jr, Ter-Pogossian MM. Evidence of the limitations of water as a freely diffusible tracer in brain of the rhesus monkey. Circ Res 1974; 35: 358-364.
20. Gjedde A, Keiding S, Vilstrup H, Iversen P. No oxygen delivery limitation in hepatic encephalopathy. Metab Brain Dis 2010; 25: 57-63.
21. 31P nuclear magnetic resonance. J Neurochem 1989; 52; 741-749.
22. Yao H, Sadoshima S, Fujii K, Kusuda K, Ishitsuka T, Tamaki K, et al. Cerebrospinal fluid lactate in patients with hepatic encephalopathy. Eur Neurol 1987; 27: 182-187.
23. Rose CF. Increase brain lactate in hepatic encephalopathy: cause or consequence? Neurochem Int 2010; 57: 389-394.
24. Lai JC, Cooper AJ. Brain alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem 1986; 47: 1376-1386.
25. Bak LK, Iversen P, Sørensen M, Keiding S, Vilstrup H, Ott P. Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. Metab Brain Dis 2009; 24: 135-145.
26. Johansen ML, Bak LK, Schousboe A, Iversen P, Sørensen M, Keiding S. The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes. Neurochem Int 2007; 50: 1042-1051.
27. Weissenborn K, Ahl B, Fischer-Wasels D, Van den Hoff J, Hecker H, Burchert W, et al. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007; 56: 1736-1742.
28. Vergara F, Plum F, Duffy T. Alpha-ketoglutaramate: increased concentrations in the cerebrospinal fluid of patients in hepatic coma. Science 1974; 183: 81-83.
29. Córdoba J, García-Martinez R, Simón-Talero M. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis 2010; 25: 73-80.
30. Guevara M, Baccaro ME, Ríos J, Martín-Llahí M, Uriz J, Ruiz del Arbol L, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int 2010; 30: 1137-1142.
31. Guevara M, Baccaro ME, Torre A, Gómez-Ansón B, Ríos J, Torres F, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol 2009; 104: 1382-1389.